JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Limited will hold a board meeting on Monday, November 2, 2026, to consider and approve the un-audited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026, according to a regulatory filing. The trading window for the company will be closed from October 1, 2026, and remain so until 48 hours after the announcement of the financial results.

JHS Svendgaard Laboratories Limited informed the Bombay Stock Exchange Limited and National Stock Exchange of India Limited that it is enclosing a certificate for the quarter ended September 30, 2026, issued by Beetal Financial & Computer Services Private Limited, in compliance with Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Vivid Mercantile Ltd, Ester Industries Ltd, Essar Shipping Ltd and TVS Electronics Ltd are among the other gainers in the BSE's 'B' group today, 30 September 2026.JHS Svendgaard Laboratories Ltd surged 20.00% to Rs 12.54 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 5.41 lakh shares were traded on the counter so far as against the average daily volumes of 22395 shares in the past one month. Vivid Mercantile Ltd spiked 18.84% to Rs 5.93. The stock was the second biggest gainer in 'B' group. On the BSE, 5.81 lakh shares were traded on the counter so far as against the average daily volumes of 1.83 lakh shares in the past one month. Ester Industries Ltd soared 17.48% to Rs 99.49. The stock was the third biggest gainer in 'B' group. On the BSE, 2.34 lakh shares were traded on the counter so far as against the average daily volumes of 3598 shares in the past one month. Essar Shipping Ltd added 17.43% to Rs 19.94. The stock was the fourth biggest gainer in 'B' group. On the BSE, 8.81 lakh shares were traded on the counter so far as against the average daily volumes of 27170 shares in the past one month. TVS Electronics Ltd rose 14.01% to Rs 427.2. The stock was the fifth biggest gainer in 'B' group. On the BSE, 65489 shares were traded on the counter so far as against the average daily volumes of 2454 shares in the past one month.

JHS Svendgaard Laboratories Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for dealing in the company's securities will be closed for insiders, including designated persons and their immediate relatives, from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30, 2026.

JHS Svendgaard Laboratories Ltd share price inched up 1.15% to Rs 7.95. The Company's net profit witnessed a sharp fall of 130.53% to Rs 1.09 crore, while revenue from operations eased by 7.09% to Rs 30.38 crore in Q2FY26 over Q1FY26. The market capitalization of Personal Care industry group stocks on BSE stood at Rs 3.57 lakh crore, climbing 14.21%. It has slipped by 0.66% over last one week and gained upto 1.30% in last one month while the market capitalization of JHS Svendgaard Laboratories Ltd has significantly gained 17.55% and 1.67% in the same period respectively. Profit before tax (PBT) of JHS Svendgaard Laboratories Ltd stood at Rs 0.06 crore in Q2 FY26, nosediving by 90.48% year-on-year, and tumbling by 102.01% quarter-on-quarter. EBITDA came in at Rs 2 crore, surging by 197.01% YoY and tanking 184.68% sequentially. Total expenses fell by 16.72% to Rs 30.13 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 18.73 crore, plunging by 23.58% YoY, while employee benefits expense was at Rs 2.87 crore, falling 7.72% YoY. For the TTM ended FY26, revenue from operations soared by 29.94% to Rs 92.0 crore, while net profit jumped 386.21% to Rs 19.74 crore, compared to previous TTM. EBITDA saw a sharp decline of 464% to Rs 6.89 crore, and PBT soared 264.72% to Rs 12.51 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 5.18 crore in FY26, as against Rs 9.18 crore in FY25. JHS Svendgaard Laboratories Ltd nosedived by 32.57% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.56% during the same period.

JHS Svendgaard Laboratories Limited informed the Bombay Stock Exchange Limited and National Stock Exchange of India Limited that it has filed a statement of deviation or variation under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended June 30, 2026, regarding the utilization of Rs 29.99 crore raised through a preferential issue on June 4, 2024, with Rs 764.46 crore utilized for setting up a new project in Jammu & Kashmir, Rs 749.50 crore for general corporate purposes, and Rs 962.50 crore infused into JHS Svendgaard Retail Ventures Ltd.

JHS Svendgaard Laboratories Limited will hold a board meeting on Tuesday, August 11, 2026, to consider and approve the un-audited financial results (standalone and consolidated) for the quarter ended June 30, 2026, according to a regulatory filing with the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. The company’s trading window has been closed since July 1, 2026, and will remain closed for 48 hours following the announcement of the results.

Net Loss of JHS Svendgaard Laboratories reported to Rs 3.57 crore in the quarter ended March 2026 as against net loss of Rs 6.96 crore during the previous quarter ended March 2025. Sales rose 29.92% to Rs 32.70 crore in the quarter ended March 2026 as against Rs 25.17 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 1.92 crore in the year ended March 2026 as against net loss of Rs 19.74 crore during the previous year ended March 2025. Sales rose 10.53% to Rs 101.69 crore in the year ended March 2026 as against Rs 92.00 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales32.7025.17 30 101.6992.00 11 OPM %-4.98-21.33 -2.57-4.36 - PBDT-1.13-4.17 73 5.21-1.70 LP PBT-2.98-6.19 52 -2.29-9.65 76 NP-3.57-6.96 49 -1.92-19.74 90 Powered by Capital Market - Live

JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 26 May 2026.

Net profit of JHS Svendgaard Laboratories reported to Rs 0.79 crore in the quarter ended December 2025 as against net loss of Rs 1.84 crore during the previous quarter ended December 2024. Sales rose 2.69% to Rs 23.27 crore in the quarter ended December 2025 as against Rs 22.66 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales23.2722.66 3 OPM %7.181.10 - PBDT1.980.39 408 PBT0.08-1.58 LP NP0.79-1.84 LP Powered by Capital Market - Live